USFDA approves intramuscular administration for Merck’s MMRV Family of Vaccines: M-M-RII, VARIVAX, ProQuad Ruchika Sharma7 March 2023 11:22 AM ISTProQuad is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12...
Merck scraps another prostate cancer study as Keytruda therapy disappoints Ruchika Sharma1 March 2023 2:15 PM ISTNew Delhi: Merck & Co said on Tuesday it will stop a late-stage trial evaluating a combination therapy with its cancer drug Keytruda after interim...
Moderna-Merck gets USFDA Breakthrough Therapy Designation for personalized mRNA cancer vaccine in combination with KEYTRUDA to treat high risk melanoma Ruchika Sharma23 Feb 2023 2:45 PM ISTCambridge: Moderna, Inc. and Merck have announced that mRNA-4157/V940, an investigational personalized mRNA cancer vaccine, in combination with...
LAGEVRI did not demonstrate statistically significant reduction in COVID risk following household exposure to another individual with COVID: Merck Ruchika Sharma23 Feb 2023 9:00 AM ISTRahway: Merck, known as MSD outside the United States and Canada, has announced that LAGEVRI (molnupiravir) did not demonstrate a statistically...
Merck announces positive results from phase 3 KEYNOTE-859 trial of Keytruda plus chemotherapy to treat patients with HER2-negative gastric or GEJ adenocarcinoma Ruchika Sharma20 Feb 2023 2:30 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Merck gets USFDA priority review for PREVYMIS for Prophylaxis of Cytomegalovirus Disease in kidney transplant recipients at high risk Ruchika Sharma19 Feb 2023 4:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted for...
Merck gets USFDA nod for KEYTRUDA as adjuvant treatment for non-small cell lung cancer Ruchika Sharma30 Jan 2023 2:45 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Merck set to remove cancer-causing chemical from top diabetes drugs Ruchika Sharma18 Jan 2023 1:15 PM ISTNew Jersey: Merck & Co has discovered how its blockbuster diabetes drugs have become contaminated with a potential carcinogen and believe it can...
Merck, Kelun-Biotech ink pact to develop seven investigational preclinical ADC for cancer treatment Ruchika Sharma25 Dec 2022 11:00 AM ISTKelun-Biotech will receive an upfront payment of $175 million from Merck.
Merck secures USFDA priority review for PADCEV with KEYTRUDA for treatment of Urothelial Cancer Ruchika Sharma22 Dec 2022 3:21 PM ISTPADCEV (enfortumab vedotin-ejfv) is a first-in-class antibody-drug conjugate (ADC) that is directed against Nectin-4, a protein located on the surface...
Centre deliberates on HPV vaccine introduction in national immunisation programme next year Ruchika Sharma19 Dec 2022 12:22 PM ISTThe government advisory panel NTAGI has also given its go-ahead for the inclusion of CERVAVAC in the public immunisation programme
Merck commences tender offer to purchase Imago BioSciences Ruchika Sharma13 Dec 2022 11:15 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that it has commenced through a subsidiary, a cash tender offer to...
